Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company’s wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation, and its vertically integrated commercial model is reshaping the delivery of prescription therapies. Cala Health’s lead product, Cala Trio™ therapy, is the only non-invasive prescription therapy for essential tremor. New therapies are under development in Parkinson’s disease and other indications in neurology, as well as targets in psychiatry, cardiology, and autoimmune disorders. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.

Cala Health's core mission is centered around revolutionizing the treatment of chronic diseases through innovative bioelectronic therapies. The company is dedicated to improving the lives of patients by developing cutting-edge, non-invasive solutions that address the root causes of various health conditions. By combining deep scientific research with advanced technology, Cala Health strives to create a lasting impact on healthcare and empower patients to take control of their well-being.

• Empathy: Cala Health values empathy, creating a culture that prioritizes understanding and compassion for patients, colleagues, and partners.
• Innovation: Cala Health fosters a culture of innovation, encouraging employees to think outside the box and develop novel solutions to improve patient care.
• Collaboration: Collaboration is key to Cala Health's success, promoting teamwork and open communication to achieve shared goals.
• Accountability: Cala Health values accountability, taking responsibility for actions and decisions to ensure the highest quality of patient care and business practices.